Insider holders · CIK 0001658247
Crinetics Pharmaceuticals, Inc. · CRNX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector | — | 2,587,953 | 2,587,953 | Aug 27, 2018 · 6:12 pm EDT | Form 4/A |
| PERCEPTIVE ADVISORS LLCDirector | — | 2,587,953 | 2,587,953 | Aug 27, 2018 · 6:12 pm EDT | Form 4/A |
| Joseph Edelman10% Owner | — | 2,587,953 | 2,587,953 | Aug 27, 2018 · 6:12 pm EDT | Form 4/A |
| Vivo Opportunity, LLC10% Owner | — | 294,357 | 294,357 | Jul 20, 2018 · 4:50 pm EDT | Form 4 |
| Vivo Opportunity Fund, L.P.10% Owner | — | 294,357 | 294,357 | Jul 20, 2018 · 4:50 pm EDT | Form 4 |
| Vivo Capital, LLC10% Owner | — | 294,357 | 294,357 | Jul 20, 2018 · 4:50 pm EDT | Form 4 |
| Vivo Capital Surplus Fund VIII, L.P.10% Owner | — | 294,357 | 294,357 | Jul 20, 2018 · 4:50 pm EDT | Form 4 |
| Vivo Capital VIII, LLC10% Owner | — | 294,357 | 294,357 | Jul 20, 2018 · 4:50 pm EDT | Form 4 |
| Vivo Capital Fund VIII, L.P.10% Owner | — | 294,357 | 294,357 | Jul 20, 2018 · 4:50 pm EDT | Form 4 |
| Wendall WierengaDirector | 74,517 | — | 74,517 | Jul 17, 2018 · 8:48 pm EDT | Form 3 |
| Marc WilsonSee Remarks | 57,321 | — | 57,321 | Feb 12, 2019 · 5:29 pm EST | Form 5 |
| Alan Seth KrasnerChief Medical Officer | 3,470 | — | 3,470 | Feb 12, 2019 · 5:25 pm EST | Form 5 |
| Andrew J. Schwab10% Owner | — | 1,723 | 1,723 | Feb 22, 2019 · 8:06 pm EST | Form 4 |
| 5AM Co-Investors IV, L.P.10% Owner | — | 1,723 | 1,723 | Feb 22, 2019 · 8:06 pm EST | Form 4 |
| 5AM Ventures IV, L.P.10% Owner | — | 1,723 | 1,723 | Feb 22, 2019 · 8:06 pm EST | Form 4 |
| 5AM Partners IV, LLC10% Owner | — | 1,723 | 1,723 | Feb 22, 2019 · 8:06 pm EST | Form 4 |
| John D Diekman10% Owner | — | 1,723 | 1,723 | Feb 22, 2019 · 8:06 pm EST | Form 4 |
| Scott M Rocklage10% Owner | — | 1,723 | 1,723 | Feb 22, 2019 · 8:06 pm EST | Form 4 |
| Isabel KalofonosChief Commercial Officer | 0 | — | 0 | Sep 1, 2026 · 4:55 pm EDT | Form 4 |
| Stephen F. BetzChief Scientific Officer | 0 | — | 0 | Sep 1, 2026 · 4:54 pm EDT | Form 4 |
| Caren DeardorfDirector | 0 | — | 0 | Sep 1, 2026 · 5:00 pm EDT | Form 4 |
| Weston NicholsDirector | 0 | — | 0 | Sep 1, 2026 · 5:01 pm EDT | Form 4 |
| Richard Scott StruthersPresident & CEO | 0 | 0 | 0 | Sep 1, 2026 · 4:52 pm EDT | Form 4 |
| Stephanie OkeyDirector | 0 | — | 0 | Sep 1, 2026 · 5:01 pm EDT | Form 4 |
| Versant Ventures V (Canada), L.P.10% Owner | — | 0 | 0 | Feb 6, 2019 · 5:35 pm EST | Form 4 |
| Tobin SchilkeChief Financial & Infra. Ofcr. | 0 | — | 0 | Sep 1, 2026 · 4:53 pm EDT | Form 4 |
| Versant Ventures V, LLC10% Owner | — | 0 | 0 | Feb 6, 2019 · 5:35 pm EST | Form 4 |
| Versant Venture Capital V (Canada), LP10% Owner | — | 0 | 0 | Feb 6, 2019 · 5:35 pm EST | Form 4 |
| Coelho Rogerio VivaldiDirector | 0 | — | 0 | Sep 1, 2026 · 5:02 pm EDT | Form 4 |
| Versant Ophthalmic Affiliates I, L.P.10% Owner | — | 0 | 0 | Feb 6, 2019 · 5:35 pm EST | Form 4 |
| Versant Venture Capital V, L.P.10% Owner | — | 0 | 0 | Feb 6, 2019 · 5:35 pm EST | Form 4 |
| Versant Affiliates Fund V, L.P.10% Owner | — | 0 | 0 | Feb 6, 2019 · 5:35 pm EST | Form 4 |
| Matthew K FustDirector | 0 | — | 0 | Sep 1, 2026 · 5:01 pm EDT | Form 4 |
| Camille L BedrosianDirector | 0 | — | 0 | Sep 1, 2026 · 5:00 pm EDT | Form 4 |
| Wendell WierengaDirector | 0 | — | 0 | Sep 1, 2026 · 5:02 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.